Incube Labs
InCube Labs is a multi-disciplinary life sciences lab focused on developing and commercializing breakthrough innovations in healthcare. Their mission is to improve patient outcomes across various therapeutic areas by addressing clinical needs with innovative solutions such as implantable devices, drug delivery systems, and interventional devices. They emphasize a process centered on understanding and framing clinical problems to develop disruptive therapies that can significantly impact patients and markets.
Industries
Nr. of Employees
medium (51-250)
Products
Oral biologics delivery platform
A platform intended to enable oral administration of biologic drugs (peptides, proteins, antibodies, vaccines) with demonstrated preclinical systemic bioavailability.
Implantable focal drug‑delivery device for CNS tumors
Implantable device designed to deliver one or more drugs directly at a brain tumor site to bypass the blood–brain barrier and minimize peripheral exposure.
Neuromodulation therapy systems
Implantable stimulation systems targeting sacral nerves or dorsal root ganglia for indications such as overactive bladder and chronic pain.
Transdermal therapy for iron deficiency
Non-oral, non-injectable transdermal formulation and delivery approach for treatment of iron deficiency anemia.
Remote patient monitoring system for active implants
Wireless system and platform for remote management and monitoring of patients with active implanted medical devices.
Gastric stimulation therapy for obesity
Implantable gastric stimulation platform intended to support weight loss by modulating gastric activity and behavior-related parameters.
Oral biologics delivery platform
A platform intended to enable oral administration of biologic drugs (peptides, proteins, antibodies, vaccines) with demonstrated preclinical systemic bioavailability.
Implantable focal drug‑delivery device for CNS tumors
Implantable device designed to deliver one or more drugs directly at a brain tumor site to bypass the blood–brain barrier and minimize peripheral exposure.
Neuromodulation therapy systems
Implantable stimulation systems targeting sacral nerves or dorsal root ganglia for indications such as overactive bladder and chronic pain.
Transdermal therapy for iron deficiency
Non-oral, non-injectable transdermal formulation and delivery approach for treatment of iron deficiency anemia.
Remote patient monitoring system for active implants
Wireless system and platform for remote management and monitoring of patients with active implanted medical devices.
Gastric stimulation therapy for obesity
Implantable gastric stimulation platform intended to support weight loss by modulating gastric activity and behavior-related parameters.
Services
Integrated services from early concept and prototyping through design refinement, industrial design, user testing, process development, and scale-up to production.
Process development, manufacturing optimization, automation, and access to ISO-certified manufacturing partner capabilities for Class II and Class III medical devices.
Clinical planning, regulatory strategy for devices, drugs and combinations, quality system implementation and preparation for regulatory submissions and audits.
Execution of complex bioanalytical assays, analytical biochemistry, pharmacology, and preclinical disease model studies to generate endpoints for biologics and device programs.
Design and development of connectivity solutions and remote patient monitoring platforms for active implants and chronic disease management.
Formation of portfolio companies, access to venture funds and investor networks, and commercialization support through affiliated venture organizations.
Integrated services from early concept and prototyping through design refinement, industrial design, user testing, process development, and scale-up to production.
Process development, manufacturing optimization, automation, and access to ISO-certified manufacturing partner capabilities for Class II and Class III medical devices.
Clinical planning, regulatory strategy for devices, drugs and combinations, quality system implementation and preparation for regulatory submissions and audits.
Execution of complex bioanalytical assays, analytical biochemistry, pharmacology, and preclinical disease model studies to generate endpoints for biologics and device programs.
Design and development of connectivity solutions and remote patient monitoring platforms for active implants and chronic disease management.
Formation of portfolio companies, access to venture funds and investor networks, and commercialization support through affiliated venture organizations.
Expertise Areas
- Implantable device development
- Drug–device combination development
- Oral biologics delivery
- Biomaterials and tissue engineering
Key Technologies
- Neuromodulation therapy systems
- Implantable drug‑delivery devices
- Oral biologic delivery platforms
- Transdermal drug delivery